Telomerase Reverse Transcriptase and Peroxisome Proliferator-Activated Receptor γ Co-Activator-1α Cooperate to Protect Cells from DNA Damage and Mitochondrial Dysfunction in Vascular Senescence

Rejuvenation Research

Volumn 18, Issue 5, 2015, Pages 479-483

  Mendelsohn, Andrew R ^a   Larrick, James W ^a  

^a Panorama Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BETA GALACTOSIDASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA; GENOMIC DNA; HEME OXYGENASE 1; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; TELOMERASE REVERSE TRANSCRIPTASE; THIOCTIC ACID; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL AGING; CELL PROTECTION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; LIPID DIET; LONGEVITY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; UPREGULATION; ANIMAL; BLOOD VESSEL; GENETICS; GROWTH, DEVELOPMENT AND AGING;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; DNA DAMAGE; TELOMERE SHORTENING; TRANSCRIPTION FACTORS;

EID: 84945545102     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2015.1780     Document Type: Review

References (28)

1. Choudhary B, Karande AA, Raghavan SC. Telomere and telomerase in stem cells: Relevance in ageing and disease. Front Biosci Sch Ed 2012;4:16-30.
2. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev 2008;129:467-474.
3. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011;470:359-365.
4. Xiong S, Salazar G, Patrushev N, Ma M, Forouzandeh F, Hilenski L, Alexander RW. Peroxisome proliferatoractivated receptor c coactivator-1a is a central negative regulator of vascular senescence. Arterioscler Thromb Vasc Biol 2013;33:988-998.
5. Donate LE, Blasco MA. Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci 2011;366:76-84.
6. Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011;21:349-353.
7. Xiong S, Patrushev N, Forouzandeh F, Hilenski L, Alexander RW. PGC-1a modulates telomere function and DNA damage in protecting against aging-related chronic diseases. Cell Rep 2015;12:1391-1399.
8. Haendeler J, Dröse S, Büchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, Zeiher AM, Brandt U, Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 2009;29:929-935.
9. Patten IS, Arany Z. PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab 2012;23:90-97.
10. Vriend J, Reiter RJ. The Keap1-Nrf2-antioxidant response element pathway: A review of its regulation by melatonin and the proteasome. Mol Cell Endocrinol 2015;401:213-220.
11. Zhang W-J, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B. Dietary a-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 2008;117:421-428.
12. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006;127:397-408.
13. Reusch JEB, Klemm DJ. Cyclic AMP response elementbinding protein in the vessel wall good or bad? Circulation 2003;108:1164-1166.
14. Wang JC, Bennett M. Aging and atherosclerosis mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012;111:245-259.
15. Larrick JW, Mendelsohn AR. Telomerase redux: Ready for prime time? Rejuvenation Res 2015;18:185-187.
16. Nebbioso M, Pranno F, Pescosolido N. Lipoic acid in animal models and clinical use in diabetic retinopathy. Expert Opin Pharmacother 2013;14:1829-1838.
17. Han T, Bai J, Liu W, Hu Y. A systematic review and metaanalysis of a-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol Eur Fed Endocr Soc 2012;167:465-471.
18. Pagano G, Aiello Talamanca A, Castello G, Cordero MD, d'Ischia M, Gadaleta MN, Pallardó FV, Petrović S, Tiano L, Zatterale A. Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: Rational design of chemoprevention trials. Int J Mol Sci 2014;15:20169-20208.
19. Ajith TA, Jayakumar TG. Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases. World J Cardiol 2014;6:1091-1099.
20. Koufaki M. Therapeutic applications of lipoic acid: A patent review (2011-2014). Expert Opin Ther Pat 2014;24:993-1005.
21. Park S, Karunakaran U, Jeoung NH, Jeon J-H, Lee I-K. Physiological effect and therapeutic application of alpha lipoic acid. Curr Med Chem 2014;21:3636-3645.
22. Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, Palmer AK, Ikeno Y, Hubbard GB, Lenburg M, O'Hara SP, LaRusso NF, Miller JD, Roos CM, Verzosa GC, LeBrasseur NK,Wren JD, Farr JN, Khosla S, StoutMB, McGowan SJ, Fuhrmann-Stroissnigg H, Gurkar AU, Zhao J, Colangelo D, Dorronsoro A, Ling YY, Barghouthy AS, Navarro DC, Sano T, Robbins PD, Niedernhofer LJ, Kirkland JL. The Achilles' heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 2015:14:644-658.
23. Lee C-K, Pugh TD, Klopp RG, Edwards J, Allison DB, Weindruch R Prolla TA. The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice. Free Radic Biol Med 2004;36: 1043-1057.
24. Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 2012:4:691-704.
25. Salinthone S, Schillace RV, Tsang C, Regan JW, Bourdette DN, Carr DW. Lipoic acid stimulates cAMP production via G protein coupled receptor dependent and independent mechanisms. J Nutr Biochem 2011;22:681-690.
26. van Leeuwen N, Beekman M, Deelen J, van den Akker EB, de Craen AJM, Slagboom PE, 't Hart LM. Low mitochondrial DNA content associates with familial longevity: The Leiden Longevity Study. Age 2014;36:9629.
27. Clark J, Reddy S, Zheng K, Betensky RA, Simon DK. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. BMC Med Genet 2011;12:69.
28. Shibata N, Motoi Y, Tomiyama H, Ohnuma T, Kuerban B, Tomson K, Komatsu M, Shimazaki H, Hattori N, Arai H. Lack of genetic associations of PPAR-c and PGC-1a with Alzheimer's disease and Parkinson's disease with dementia. Dement Geriatr Cogn Disord Extra 2013;3:161-167.